Skip to main content

Table 1 Socio-demographic and clinical characteristics of the study subjects (n = 192)

From: Validation of the Japanese version of the EORTC hepatocellular carcinoma-specific quality of life questionnaire module (QLQ-HCC18)

Male gender 122 (63.5)
Age, y* 68.1 (8.5)
Employed full time or part-time 77 (40.1)
Post compulsory education or above 155 (80.7)
Married or living with partner 151 (78.6)
Karnofsky Performance status  
80-100 166 (86.5)
Comorbid liver disease  
Hepatitis C virus 126 (65.6)
Hepatitis B virus 38 (19.8)
Other or unknown 28 (14.6)
Child-Pugh class  
A 127 (66.1)
B 53 (27.6)
C 12 (6.3)
Cancer stage  
Stage I / II 161 (83.9)
Stage III / IV 31 (16.1)
Time since diagnosis, month* 39.6 (34.5)
Past medical history  
Hepatectomy 48 (25.0)
Percutaneous ablation 137 (71.4)
Chemoembolization 64 (33.3)
Systemic therapy 1 (0.5)
No medical history 13 (6.8)
  1. Values are numbers (%) otherwise specified. * Data was expressed as mean (standard deviation). Some patients underwent multiple treatments.